MAM
Ernst & Young announces new leadership in India
NEW DELHI: A new leadership for Ernst & Young in India was decided at a meeting of the firm’s partners. The impending retirement of chairman and country managing partner (CMP) Kashi Memani will retire next year.
The partners unanimously elected Jairaj Purandare as the firm’s chairman and Rajiv Memani as the new country managing partner and CEO. Both these new positions take effect from 1 April 2004.
An official release informs that prior to the integration of Arthur Andersen and Ernst & Young in May 2001 Purandare was the national tax head for Andersen. Rajiv currently leads Ernst & Young India’s corporate finance practice. Ernst & Young Global’s COO Paul Ostling added, “With its immense intellectual talent and the emergence of Indian enterprise at the global level, we see tremendous potential for our Indian practice.
” The global executive board of Ernst & Young offers its complete support to the firm in India. We are confident that the new leadership will sustain and further grow the firm’s number one position in the country.”
Memani added, “The direction of Ernst & Young Global, support of our clients and the commitment of our people, has today made us the number one professional services firm. The partners in our new leadership have demonstrated their capabilities having successfully managed and led our different service lines over the years. With the economy on a growth track, I am certain that the new team will infuse energy and youthful vigour to help maintain our lead in the marketplace.”
Ernst & Young offers assurance and advisory business services, tax advisory, corporate finance and transaction services.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
